{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:14:30Z","timestamp":1791688470765,"version":"4.3.4"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DK007568"],"award-info":[{"award-number":["T32DK007568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.07.009","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:55:48Z","timestamp":1693011348000},"page":"193-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence"],"prefix":"10.1016","volume":"28","author":[{"given":"Jacqueline B.","family":"Henson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay Y.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","article-title":"Acute rejection increases risk of graft failure and death in recent liver transplant recipients","volume":"15","author":"Levitsky","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2023.07.009_bib3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/00365521.2015.1036359","article-title":"Liver transplantation in the Nordic countries - an intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013","volume":"50","author":"Fosby","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-199602270-00007","article-title":"The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation","volume":"61","author":"Berlakovich","year":"1996","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","article-title":"Allograft rejection after liver transplantation for autoimmune liver diseases","volume":"4","author":"Hayashi","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200008150-00014","article-title":"Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors","volume":"70","author":"Milkiewicz","year":"2000","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transpl"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-6143.2008.02487.x","article-title":"Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation","volume":"9","author":"Shaked","year":"2009","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/liv.15500","article-title":"Liver transplantation for autoimmune hepatitis: pre-transplant does not predict the early post-transplant outcome","volume":"43","author":"Chouik","year":"2023","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A\u00a010 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vall\u00e9e","year":"2003","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0012.2007.00788.x","article-title":"Late acute rejection after liver transplantation impacts patient survival","volume":"22","author":"Uemura","year":"2008","journal-title":"Clin Transpl"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","author":"Thurairajah","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib18","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/TXD.0000000000000693","article-title":"Outcomes of liver transplant recipients with autoimmune liver disease using long-term dual immunosuppression regimen without corticosteroid","volume":"3","author":"Satapathy","year":"2017","journal-title":"Transpl Direct"},{"issue":"11","key":"10.1016\/j.cld.2023.07.009_bib19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.1840220213","article-title":"Liver transplantation for sclerosing cholangitis","volume":"22","author":"Narumi","year":"1995","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2023.07.009_bib21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/bjs.1800820836","article-title":"Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation","volume":"82","author":"Miki","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.cld.2023.07.009_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000084","article-title":"Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation","author":"Tajima","year":"2023","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.cld.2023.07.009_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/lt.25177","article-title":"Prevalence, risk factors, and impact of donor-specific alloantibodies after adult liver transplantation","volume":"24","author":"Vandevoorde","year":"2018","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2023.07.009_bib24","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"Comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transpl"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2021.07.027","article-title":"Antibody-mediated rejection of the liver allograft: an update and a clinico-pathological perspective","volume":"75","author":"Lee","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cld.1234","article-title":"Alloimmune versus autoimmune hepatitis following liver transplantation","volume":"20","author":"Harrington","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Montano-Loza","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2023.07.009_bib28","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2023.07.009_bib29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2001.23085","article-title":"Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome","volume":"7","author":"H\u00fcbscher","year":"2001","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib32","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1097\/TXD.0000000000001160","article-title":"HLA-DR mismatch and black race are associated with recurrent autoimmune hepatitis after liver transplantation","volume":"7","author":"McCabe","year":"2021","journal-title":"Transpl Direct"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National institute of diabetes and digestive and kidney diseases liver transplantation database","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12936","article-title":"Histologic surveillance after liver transplantation due to autoimmune hepatitis","volume":"31","author":"Puustinen","year":"2017","journal-title":"Clin Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.31407","article-title":"Immunosuppressive treatment regimens in autoimmune hepatitis: systematic reviews and meta-analyses supporting American association for the study of liver diseases guidelines","volume":"72","author":"Vierling","year":"2020","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2023.07.009_bib39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2020.12.005","article-title":"Risk factors for recurrent primary biliary cirrhosis after liver transplantation: a systematic review and meta-analysis","volume":"53","author":"Li","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.cld.2023.07.009_bib50","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/liv.14964","article-title":"Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation","volume":"41","author":"Lytvyak","year":"2021","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.cld.2023.07.009_bib51","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib52","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib53","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2023.07.009_bib55","doi-asserted-by":"crossref","first-page":"100599","DOI":"10.1016\/j.jhepr.2022.100599","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: an international multicentre study","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.cld.2023.07.009_bib56","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/tri.13925","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond","volume":"34","author":"Visseren","year":"2021","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study","volume":"53","author":"Lindstr\u00f6m","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib59","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib60","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2023.07.009_bib61","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib62","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib63","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transpl"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib64","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib66","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib67","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"issue":"9349","key":"10.1016\/j.cld.2023.07.009_bib68","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cld.2023.07.009_bib69","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ibd\/izz325","article-title":"Activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis predicts poorer clinical outcomes","volume":"26","author":"Peverelle","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"20","key":"10.1016\/j.cld.2023.07.009_bib70","doi-asserted-by":"crossref","first-page":"e20205","DOI":"10.1097\/MD.0000000000020205","article-title":"Risk factors for recurrent autoimmune liver diseases after liver transplantation: a meta-analysis","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib71","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/tri.13852","article-title":"Donor age (\u226545 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study","volume":"34","author":"Akamatsu","year":"2021","journal-title":"Transpl Int"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib72","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25739","article-title":"Longterm survival after liver transplantation for autoimmune hepatitis: results from the European liver transplant registry","volume":"26","author":"Heinemann","year":"2020","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib73","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib74","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/liv.15552","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis: a French nationwide study over 30 years","volume":"43","author":"Chouik","year":"2023","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib75","first-page":"381","article-title":"Evidence for spontaneous immunosuppression in autoimmune hepatitis","volume":"22","author":"Lohse","year":"1995","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2023.07.009_bib76","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT: long-term follow-up and predictive factors","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib77","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2004-1978","article-title":"Osteoporosis after solid organ transplantation","volume":"90","author":"Maalouf","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.cld.2023.07.009_bib78","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/j.1572-0241.2000.02269.x","article-title":"Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation","volume":"95","author":"Trautwein","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib79","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis","volume":"14","author":"Eastell","year":"1991","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2023.07.009_bib80","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.21805","article-title":"Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors","volume":"46","author":"Guichelaar","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.20276","article-title":"Quality of life in patients with primary biliary cirrhosis","volume":"40","author":"Poupon","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib82","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2013.04.017","article-title":"The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study","volume":"59","author":"Carbone","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2023.07.009_bib83","doi-asserted-by":"crossref","first-page":"e13434","DOI":"10.1111\/ctr.13434","article-title":"Effects of liver transplantation on health-related quality of life in patients with primary biliary cholangitis","volume":"32","author":"Krawczyk","year":"2018","journal-title":"Clin Transpl"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2013.02.019","article-title":"The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort","volume":"59","author":"Pells","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib85","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/lt.26033","article-title":"Chronic fatigue persists in a significant proportion of female patients after transplantation for primary sclerosing cholangitis","volume":"27","author":"Wunsch","year":"2021","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2023.07.009_bib86","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/lt.25838","article-title":"Impact of preexisting inflammatory bowel disease on the outcome of liver transplantation for primary sclerosing cholangitis","volume":"26","author":"Irl\u00e8s-Dep\u00e9","year":"2020","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib88","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ibd\/izx096","article-title":"Natural history of established and de novo inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"24","author":"Mouchli","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib89","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.dld.2020.09.011","article-title":"Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study","volume":"53","author":"Ribaldone","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib90","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/MIB.0000000000001105","article-title":"Clinical course of ulcerative colitis after liver transplantation in patients with concomitant primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Fattahi","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib91","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"J\u00f8rgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib92","first-page":"949","article-title":"Safety of combination biologic and antirejection therapy post-liver transplantation in patients with inflammatory bowel disease","volume":"26","author":"Al Draiweesh","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.cld.2023.07.009_bib93","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.23741","article-title":"Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"19","author":"Singh","year":"2013","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib94","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.31731","article-title":"De novo colorectal and pancreatic cancer in liver-transplant recipients: identifying the higher-risk populations","volume":"74","author":"Nasser-Ghodsi","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ibd\/izx056","article-title":"Reviewing the risk of colorectal cancer in inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"24","author":"Rao","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"8\u20139","key":"10.1016\/j.cld.2023.07.009_bib96","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/00365521.2012.685754","article-title":"Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study","volume":"47","author":"J\u00f8rgensen","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2023.07.009_bib97","first-page":"1285","article-title":"The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis","volume":"92","author":"Marchesa","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2023.07.009_bib98","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.crohns.2014.03.011","article-title":"Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"8","author":"Imam","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib99","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.16817","article-title":"Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation","volume":"22","author":"Saunders","year":"2022","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jceh.2022.07.002","article-title":"Post-transplant immunosuppression in autoimmune liver disease","volume":"13","author":"Kelly","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.07.009_bib101","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/lt.25205","article-title":"Con: steroids should not Be withdrawn in transplant recipients with autoimmune hepatitis","volume":"24","author":"Theocharidou","year":"2018","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.cld.2023.07.009_bib102","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.25206","article-title":"Pro: steroids can Be withdrawn after transplant in recipients with autoimmune hepatitis","volume":"24","author":"Kalra","year":"2018","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib103","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/TP.0000000000002147","article-title":"International liver transplantation society consensus statement on immunosuppression in liver transplant recipients","volume":"102","author":"Charlton","year":"2018","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2023.07.009_bib104","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transpl"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2023.07.009_bib105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.07.009_bib107","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.009_bib108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2023.07.009_bib109","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/lt.24703","article-title":"Outcomes of liver retransplantation in patients with primary sclerosing cholangitis","volume":"23","author":"Henson","year":"2017","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.dld.2018.02.014","article-title":"Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: a nationwide case series","volume":"50","author":"Altwegg","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.cld.2023.07.009_bib111","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/2050640619858050","article-title":"Safety of vedolizumab in liver transplant recipients: a systematic review","volume":"7","author":"Spadaccini","year":"2019","journal-title":"United Eur Gastroenterol J"},{"issue":"Supplement_2","key":"10.1016\/j.cld.2023.07.009_bib112","doi-asserted-by":"crossref","first-page":"S755","DOI":"10.1093\/ecco-jcc\/jjaa017","article-title":"JAK inhibitors safety in ulcerative colitis: practical implications","volume":"14","author":"Agrawal","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"issue":"9","key":"10.1016\/j.cld.2023.07.009_bib113","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2023.07.009_bib114","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study","volume":"34","author":"Khettry","year":"2003","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.009_bib115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2023.07.009_bib116","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/ajt.13828","article-title":"First-degree living-related donor liver transplantation in autoimmune liver diseases","volume":"16","author":"Aravinthan","year":"2016","journal-title":"Am J Transpl"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:00:22Z","timestamp":1761069622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1089326123000892"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.009","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}